Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Korsten

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
International Journal of Molecular Sciences|July 14, 2023
A Transcriptome Array-Based Approach Links Proteinuria and Distinct Molecular Signatures to Intrarenal Expression of Type I Interferon <i>IFNA5</i> in Lupus NephritisPeter Korsten, Björn Tampe
Rheumatology Advances in Practice|July 14, 2023
Avacopan improves patient perspective on steroid-related toxicity effects in a case with ANCA-associated vasculitisPeter Korsten, Björn Tampe
Rheumatology (Oxford, England)|February 22, 2022
Rituximab-a B cell targeted therapy in systemic lupus erythematosus: where do we stand?Silvia Piantoni, Peter Korsten
Lupus|February 16, 2021
Improvement of lupus-associated fatigue with modafinil: Report of two casesPeter Korsten, Silvia Piantoni
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 4, 2021
Anti-Jo-1 Syndrome Often Misdiagnosed as Rheumatoid Arthritis (for Many Years)-A Single-Center Experience Think of RA-ASyS Overlap!Jan-Gerd Rademacher, Peter Korsten
Deutsche Medizinische Wochenschrift (1946)|November 18, 2017
Peter Korsten, Gerhard A Müller
Rheumatology (Oxford, England)|July 21, 2022
IRF6 mutation in systemic sclerosis: innocent bystander or contributing factor?Jan-Gerd Rademacher, Peter Korsten
Arthritis & Rheumatology (Hoboken, N.J.)|July 24, 2015
Hypertrophic osteoarthropathy presenting as inflammatory arthritisPeter Korsten, Hanibal Bohnenberger, Radovan Vasko
Annals of the Rheumatic Diseases|July 4, 2020
Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred surveyMarlene Plüß, Gamal Chehab, Peter Korsten
Research and Practice in Thrombosis and Haemostasis|November 2, 2020
Type 2A von Willebrand disease and systemic sclerosis: Vonicog alfa reduced gastrointestinal bleedingPeter Korsten, Manuel Wallbach, Claudia Binder
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Sciences|July 14, 2023
A Transcriptome Array-Based Approach Links Proteinuria and Distinct Molecular Signatures to Intrarenal Expression of Type I Interferon <i>IFNA5</i> in Lupus NephritisPeter Korsten, Björn Tampe
Rheumatology Advances in Practice|July 14, 2023
Avacopan improves patient perspective on steroid-related toxicity effects in a case with ANCA-associated vasculitisPeter Korsten, Björn Tampe
Rheumatology (Oxford, England)|February 22, 2022
Rituximab-a B cell targeted therapy in systemic lupus erythematosus: where do we stand?Silvia Piantoni, Peter Korsten
Lupus|February 16, 2021
Improvement of lupus-associated fatigue with modafinil: Report of two casesPeter Korsten, Silvia Piantoni
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 4, 2021
Anti-Jo-1 Syndrome Often Misdiagnosed as Rheumatoid Arthritis (for Many Years)-A Single-Center Experience Think of RA-ASyS Overlap!Jan-Gerd Rademacher, Peter Korsten
Deutsche Medizinische Wochenschrift (1946)|November 18, 2017
Peter Korsten, Gerhard A Müller
Rheumatology (Oxford, England)|July 21, 2022
IRF6 mutation in systemic sclerosis: innocent bystander or contributing factor?Jan-Gerd Rademacher, Peter Korsten
Arthritis & Rheumatology (Hoboken, N.J.)|July 24, 2015
Hypertrophic osteoarthropathy presenting as inflammatory arthritisPeter Korsten, Hanibal Bohnenberger, Radovan Vasko
Annals of the Rheumatic Diseases|July 4, 2020
Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred surveyMarlene Plüß, Gamal Chehab, Peter Korsten
Research and Practice in Thrombosis and Haemostasis|November 2, 2020
Type 2A von Willebrand disease and systemic sclerosis: Vonicog alfa reduced gastrointestinal bleedingPeter Korsten, Manuel Wallbach, Claudia Binder
Pageof 15